[Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000437:Alcoholism / Q000150:complications; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000627:therapeutic use*; D001772:Blood Cell Count; D001792:Blood Platelets / Q000187:drug effects; D002908:Chronic Disease; D005260:Female; D006452:Hemoglobinometry; D006505:Hepatitis / Q000188:drug therapy*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis; D007962:Leukocytes / Q000187:drug effects; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000209:etiology; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007136:Immunoglobulins; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001379:Azathioprine; D011241:Prednisone
Immunsuppressive Therapie der chronischen aggressiven Hepatitis und der primär bilären Zirrhose.